Insider Shareholders with Direct Ownership of Galectin Therapeutics Inc (GALT)
This section provides a comprehensive overview of the insiders with direct ownership of Galectin Therapeutics Inc (GALT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
GALECTIN THERAPEUTICS INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 2,345,693 | 0 | 10,301,271 $13.4 Million | 5 |
Jan 23, 2025
Added 0.31%
|
|
|
10 X Fund, L.P.
> 10% Shareholder |
0 | 187,500 | 6,168,940 $8.02 Million | 20 |
Jul 22, 2022
Reduced 0.16%
|
|
Joel Lewis
President and CEO |
1,064,867 | 284,113 | 897,012 $1.17 Million | 85 |
Dec 23, 2024
Reduced 5.88%
|
| 18,767 | 0 | 63,682 $82,786 | 6 |
Dec 24, 2024
Added 17.46%
|
|
| 0 | 60,000 | 60,614 $78,798 | 1 |
Jan 11, 2021
Reduced 49.75%
|
|
| 21,300 | 0 | 44,769 $58,199 | 5 |
Dec 24, 2024
Added 18.26%
|
|
| 27,500 | 0 | 42,083 $54,707 | 6 |
Dec 24, 2024
Added 19.2%
|
|
|
Khurram Jamil
Chief Medical Officer |
40,000 | 13,654 | 26,346 $34,249 | 2 |
Dec 23, 2024
Reduced 34.14%
|
| 6,500 | 0 | 15,206 $19,767 | 1 |
Dec 30, 2024
Added 29.95%
|
|
|
Jack W Callicutt
Chief Financial Officer |
44,000 | 40,000 | 7,614 $9,898 | 3 |
Dec 23, 2024
Reduced 84.01%
|
| 1,000 | 0 | 1,000 $1,300 | 1 |
Jan 21, 2022
Added 50.0%
|